Terms: = Thyroid cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
12 results:
1. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
[TBL] [Abstract] [Full Text] [Related]
2. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting socs1.
Zhang W; Ji W; Zhao X
BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
[TBL] [Abstract] [Full Text] [Related]
3. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/socs1 axis in triple-negative breast cancer.
Li P; Zhou B; Lv Y; Qian Q
Hum Cell; 2019 Oct; 32(4):522-528. PubMed ID: 31456112
[TBL] [Abstract] [Full Text] [Related]
5. miR-4458 regulates cell proliferation and apoptosis through targeting socs1 in triple-negative breast cancer.
Liu X; Wang J; Zhang G
J Cell Biochem; 2019 Aug; 120(8):12943-12948. PubMed ID: 30873664
[TBL] [Abstract] [Full Text] [Related]
6. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting socs1 and MMP16.
Zhang W; Chen CJ; Guo GL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
[TBL] [Abstract] [Full Text] [Related]
7. socs1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer.
Qian Q; Lv Y; Li P
IUBMB Life; 2018 Apr; 70(4):320-327. PubMed ID: 29527785
[TBL] [Abstract] [Full Text] [Related]
8. Significance of expression of suppressor of cytokine signaling proteins: Suppressor of cytokine signaling-1, suppressor of cytokine signaling-2, and suppressor of cytokine signaling-3 in papillary thyroid cancer.
Kobawala TP; Trivedi TI; Gajjar KK; Patel GH; Ghosh NR
J Cancer Res Ther; 2017; 13(2):337-345. PubMed ID: 28643757
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of pro-inflammatory genes and down-regulation of socs-1 in human PTC and in hypoxic BCPAP cells.
De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
[TBL] [Abstract] [Full Text] [Related]
10. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.
Francipane MG; Eterno V; Spina V; Bini M; Scerrino G; Buscemi G; Gulotta G; Todaro M; Dieli F; De Maria R; Stassi G
Cancer Res; 2009 Aug; 69(15):6141-8. PubMed ID: 19638576
[TBL] [Abstract] [Full Text] [Related]
11. MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.
Siragusa M; Zerilli M; Iovino F; Francipane MG; Lombardo Y; Ricci-Vitiani L; Di Gesù G; Todaro M; De Maria R; Stassi G
Cancer Res; 2007 Jun; 67(11):5522-30. PubMed ID: 17545635
[TBL] [Abstract] [Full Text] [Related]
12. Fine needle sampling without aspiration.
Kumarasinghe MP; Sheriffdeen AH
Pathology; 1995 Oct; 27(4):330-2. PubMed ID: 8771150
[TBL] [Abstract] [Full Text] [Related]
